NCT02687542: Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
- State
- Stopped early
- Phase
- Phase 2
- People
- 108 taking part
- Started
- 3 Mar 2016
- Primary completion
- 10 Nov 2017
- Arms
- PF-06649751 low dose (1 mg QD)
- Results
- Posted on the registry
- 22 Feb 2016: Trial registered
- 3 Mar 2016: Trial started
- 10 Nov 2017: Trial terminated
- 24 Dec 2018: Trial results posted